Inventor

BACKFISCH GISELA

DE15 patents

⚠️ This page may combine multiple inventors who share the name “BACKFISCH GISELA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ABBOTT GMBH & CO KG

4 patents

US7144902B1Dec 5, 2006

Prodrugs of thrombin inhibitors

ABBOTT GMBH & CO KG23 citations91

US8343959B2Jan 1, 2013

N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor

ABBOTT GMBH & CO KG5 citations72

US8362010B2Jan 29, 2013

Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor

ABBOTT GMBH & CO KG2 citations61

US7851463B2Dec 14, 2010

Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

ABBOTT GMBH & CO KG2 citations61

ABBVIE DEUTSCHLAND

3 patents

US9573950B2Feb 21, 2017

Substituted [1,4]diazepino[6,7,1-ij]quinolines as serotonin 5-HT2C receptor modulators

ABBVIE DEUTSCHLAND2 citations57

US9150545B2Oct 6, 2015

Carboxamide compounds and their use as calpain inhibitors V

ABBVIE DEUTSCHLAND0 citations40

US9540376B2Jan 10, 2017

Hexahydrodiazepinoquinolines carrying a substituted alkyl radical

ABBVIE DEUTSCHLAND0 citations35

KLING ANDREAS

3 patents

US8598211B2Dec 3, 2013

Carboxamide compounds and their use as calpain inhibitors IV

KLING ANDREAS1 citations49

US9051304B2Jun 9, 2015

Carboxamide compounds and their use as calpain inhibitors V

KLING ANDREAS0 citations38

US9062027B2Jun 23, 2015

Carboxamide compounds and their use as calpain inhibitors V

KLING ANDREAS0 citations37

HAUPT ANDREAS

2 patents

US8076326B2Dec 13, 2011

N-phenyl- (piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor

HAUPT ANDREAS23 citations90

US8183237B2May 22, 2012

Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor

HAUPT ANDREAS4 citations60

DRESCHER KARLA

1 patent

US8470810B2Jun 25, 2013

Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

DRESCHER KARLA0 citations49

UNGER LILIANE

1 patent

US8101754B2Jan 24, 2012

Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

UNGER LILIANE1 citations44

HORNBERGER WILFRIED

1 patent

US9150553B2Oct 6, 2015

Carboxamide compounds and their use as calpain inhibitors

HORNBERGER WILFRIED0 citations30